title: The mTORC pathway in the antiphospholipid syndrome.
authors: From the Departments of Medicine (J.W.E., J.I.W.) and Biochemistry and Biomedical Sciences (J.I.W.), the Population Health Research Institute (J.W.E.), and the Thrombosis and Atherosclerosis Research Institute (J.W.E., J.I.W.), McMaster University, Hamilton, ON, Canada.
authors: John W
authors: JW
authors: Eikelboom
authors: Jeffrey I
authors: JI
authors: Weitz
mesh_terms: D017152:Antibodies, Antiphospholipid / Q000378:metabolism*; D016736:Antiphospholipid Syndrome / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000378:metabolism*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D020123:Sirolimus / Q000494:pharmacology*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D017152:Antibodies, Antiphospholipid; D007166:Immunosuppressive Agents; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus